Skip to content

A multicenter real world registry study of penetrating Schlemm canaloplasty

A multicenter real world registry study of penetrating Schlemm canaloplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128448
Enrollment
Unknown
Registered
2026-07-21
Start date
2021-09-22
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

Glaucoma Observation Group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Various refractory glaucomas: Glaucoma that failed after previous filtering surgery, childhood glaucoma, various secondary glaucomas caused by various reasons, such as neovascular glaucoma, glaucoma secondary to uveitis, glaucoma secondary to trauma, glaucoma secondary to iridocorneal endothelial syndrome, glaucoma secondary to Sturge-Weber syndrome, glaucoma secondary to vitrectomy, etc.; 2. With indications for glaucoma surgery: The target intraocular pressure has not been reached through medication or the patient cannot tolerate medication treatment, or the patient requests surgical treatment.

Exclusion criteria

Exclusion criteria: 1. The overall condition is not suitable for ophthalmic surgery; 2. Patients in whom it was found that the Schlemm's canal could not be penetrated through 360 degrees and alternative surgical methods had to be adopted; 3. Those with poor compliance and unable to cooperate in completing all ophthalmic and systemic related examinations; 4. Patients currently using anticoagulant drugs, with the International Normalized Ratio (INR) being > 3.0 in routine preoperative examinations; 5. Patients who underwent other glaucoma surgical methods during follow-up may affect the evaluation of therapeutic effect (and will be counted as a failure of this surgery).

Design outcomes

Primary

MeasureTime frame
Intraocular pressure;The number of antiglaucoma medications;Surgical succes rate;

Secondary

MeasureTime frame
Best corrected visual acuity;Complication;

Countries

China

Contacts

Public ContactLi Tang

West China Hospital of Sichuan University

tangli-1a@wchscu.cn+86 28 8542 2538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026